RL
Rudy Li Chardan Capital Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
28
Avg Return
Past Year
Past Year
35%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
100%
Neutral
0%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Buy
Maintained
| $330 |
83%
upside
| 3 | +86% |
0
%
| 17 Oct ‘25 3 days ago |
|
|
|
Buy
Maintained
| $55 |
27%
upside
| 4 | +5.8% |
0
%
| 7 Oct ‘25 13 days ago |
|
|
|
Buy
Initiated
| $3 |
256%
upside
| 1 | -10% |
0
%
| 29 Sep ‘25 21 days ago |
|
|
|
Buy
Initiated
| $15 |
37%
upside
| 1 | +186% |
0
%
| 29 Sep ‘25 21 days ago |
|
|
|
Buy
Initiated
| $2 |
267%
upside
| 1 | +87% |
0
%
| 29 Sep ‘25 21 days ago |
|
|
|
Buy
Maintained
| $18 |
72%
upside
| 6 | -2.5% |
0
%
| 28 Aug ‘25 1 month ago |
|
|
|
Buy
Maintained
| $24 |
29%
downside
| 4 | +45% |
0
%
| 13 Aug ‘25 2 months ago |
|
|
|
Buy
Maintained
| $30 |
31%
upside
| 3 | +24% |
0
%
| 12 Aug ‘25 2 months ago |
|
|
|
Buy
Maintained
| $20 |
53%
upside
| 3 | +26% |
0
%
| 1 Aug ‘25 2 months ago |
|
|
|
Buy
Maintained
| $80 |
22%
upside
| 2 | +53% |
0
%
| 21 May ‘25 5 months ago |
|